In the article ‘Prostate Cancer. A Review‘, published in the prestigious America medical journal JAMA, the authors say that prostate cancer is the second most common cancer in men worldwide with almost 1,466,680 new cases and 396,792 deaths in 2022. Adenocarcinoma is the most common type of prostate cancer, responsible for  99% of cases, and the average age at diagnosis is 67 years.

In a EAU podcast, Monique Roobol and Tamás Fazekas talk about the challenges and opportunities of prostate cancer screening and highlight the need to balance the benefits of early detection with the risks of overdiagnosis.

We hope that you have seen our article on the first results from our survey on shared decision making in our previous Update.

The Europa Uomo Patient Reported Shared decision making Study (EU-PRESS) has concluded that the more men are involved in decisions about their prostate cancer, the better their resulting quality of life. The research also found that shared decision-making results in men having fewer regrets about decisions made.

Read the full article here.

The EAU Patient Office has unveiled the newly redesigned EAU Patient platform – the resource for urological information targeted at men with prostate cancer. It offers reliable content based on the EAU Guidelines in easy language, a shared decision making tool and a chatbot.

The Patient Centered Solutions team at IQVIA compîled a new book entitled ‘Patient-centricity in the Biopharmaceutical Industry: Are We Nearly There Yet?’

The book gathers insights on patient-centric intervention development from a group of more than 30 experts, including pharma company executives, biotech manufacturers, regulatory representatives, patient representatives, patient advocacy group leaders, patient experience data researchers, and payer and HTA advisors.

Active Survaillance Patients International has built an Active Surveillance Short Video Library – a growing collection of short videos navigating active surveillance patients’ journeys.